Mateu-Gelabert P - Search Results

1

Inactivation and survival of hepatitis C virus on inanimate surfaces.

Doerrbecker J, Friesland M, Ciesek S, Erichsen TJ, Mateu-Gelabert P, Steinmann J, Steinmann J, Pietschmann T, Steinmann E. Doerrbecker J, et al. J Infect Dis. 2011 Dec 15;204(12):1830-8. doi: 10.1093/infdis/jir535. Epub 2011 Oct 19. J Infect Dis. 2011. PMID: 22013220 Free PMC article.

2

Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.

Doerrbecker J, Behrendt P, Mateu-Gelabert P, Ciesek S, Riebesehl N, Wilhelm C, Steinmann J, Pietschmann T, Steinmann E. Doerrbecker J, et al. J Infect Dis. 2013 Jan 15;207(2):281-7. doi: 10.1093/infdis/jis677. Epub 2012 Nov 5. J Infect Dis. 2013. PMID: 23129759 Free PMC article.

3

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs.

Siddharta A, Pfaender S, Malassa A, Doerrbecker J, Anggakusuma, Engelmann M, Nugraha B, Steinmann J, Todt D, Vondran FW, Mateu-Gelabert P, Goffinet C, Steinmann E. Siddharta A, et al. Sci Rep. 2016 Nov 18;6:36619. doi: 10.1038/srep36619. Sci Rep. 2016. PMID: 27857152 Free PMC article.

4

Hepatitis C virus risk among young people who inject drugs.

Mateu-Gelabert P, Sabounchi NS, Guarino H, Ciervo C, Joseph K, Eckhardt BJ, Fong C, Kapadia SN, Huang TTK. Mateu-Gelabert P, et al. Front Public Health. 2022 Jul 29;10:835836. doi: 10.3389/fpubh.2022.835836. eCollection 2022. Front Public Health. 2022. PMID: 35968435 Free PMC article.

5

Strategies to avoid opiate withdrawal: implications for HCV and HIV risks.

Mateu-Gelabert P, Sandoval M, Meylakhs P, Wendel T, Friedman SR. Mateu-Gelabert P, et al. Int J Drug Policy. 2010 May;21(3):179-85. doi: 10.1016/j.drugpo.2009.08.007. Epub 2009 Sep 27. Int J Drug Policy. 2010. PMID: 19786343 Free PMC article.

6

Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention.

Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, Berbesi D, Toro-Tobón D, Goodbody E, Ompad DC, Friedman SR. Mateu-Gelabert P, et al. Curr HIV/AIDS Rep. 2018 Aug;15(4):324-335. doi: 10.1007/s11904-018-0406-z. Curr HIV/AIDS Rep. 2018. PMID: 29931468 Free PMC article. Review.

7

How can hepatitis C be prevented in the long term?

Mateu-Gelabert P, Treloar C, Calatayud VA, Sandoval M, Zurián JC, Maher L, Rhodes T, Friedman SR. Mateu-Gelabert P, et al. Int J Drug Policy. 2007 Oct;18(5):338-40. doi: 10.1016/j.drugpo.2007.06.001. Epub 2007 Jul 24. Int J Drug Policy. 2007. PMID: 17854720 Free PMC article.

8

Correlates of staying safe behaviors among long-term injection drug users: psychometric evaluation of the staying safe questionnaire.

Vazan P, Mateu-Gelabert P, Cleland CM, Sandoval M, Friedman SR. Vazan P, et al. AIDS Behav. 2012 Aug;16(6):1472-81. doi: 10.1007/s10461-011-0079-8. AIDS Behav. 2012. PMID: 22038081 Free PMC article.

9

Resilience among IDUs: planning strategies to help injection drug users to protect themselves and others from HIV/HCV infections.

Sirikantraporn S, Mateu-Gelabert P, Friedman SR, Sandoval M, Torruella RA. Sirikantraporn S, et al. Subst Use Misuse. 2012 Aug;47(10):1125-33. doi: 10.3109/10826084.2012.682324. Epub 2012 May 10. Subst Use Misuse. 2012. PMID: 22574849 Free PMC article.

10

The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection.

Mateu-Gelabert P, Gwadz MV, Guarino H, Sandoval M, Cleland CM, Jordan A, Hagan H, Lune H, Friedman SR. Mateu-Gelabert P, et al. AIDS Educ Prev. 2014 Apr;26(2):144-57. doi: 10.1521/aeap.2014.26.2.144. AIDS Educ Prev. 2014. PMID: 24694328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page